Supplementary Figure 4 from Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer
posted on 2023-03-31, 21:41authored byRaju Kandimalla, Feng Gao, Takatoshi Matsuyama, Toshiaki Ishikawa, Hiroyuki Uetake, Naoki Takahashi, Yasuhide Yamada, Carlos Becerra, Scott Kopetz, Xin Wang, Ajay Goel
Supplementary Figure 4: MRC significantly predicted benefit of adjuvant chemotherapy in microsatellite stable stage III colorectal cancers KM plots depicted in panel A, B, C and D belong to MRC high risk category, while the KM plots in panel E, F, G and H belong to MRC low risk category. KM plots in panel A and E represents the analysis performed on combined stage II and III CRC patients, while panel B and F represents stage II analysis and panel C and G represents stage III patient's analysis separately. KM plots depicted in panel D and H represents the analysis performed on microsatellite stable stage III CRC patients.
Funding
National Cancer Institute
NIH
Cancer Prevention Research Institute of Texas
Baylor Foundation and Baylor Scott & White Research Institute
Research Grants Council of the Hong Kong Special Administrative Region, China
Science Technology and Innovation Committee of Shenzhen